We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDP
RNS Number : 2747S
InnovaDerma PLC
19 December 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are InnovaDerma Plc attached: ii ============================================== ====================== 2 Reason for the notification (please tick the appropriate box or boxes): ---------------------------------------------------------------------- An acquisition or disposal of voting rights ============================================== ---------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ============================================== ---------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ============================================== ---------------------- An event changing the breakdown of voting rights ============================================== ---------------------- Other (please specify): ============================================== ====================== 3. Full name of person(s) subject to the notification obligation: Jenepé Limited iii ============================================== ====================== 4. Full name of shareholder(s) (if different from 3.):iv N/a ============================================== ====================== 5. Date of the transaction and date on which the threshold 16th December 2016 is crossed or reached: v ============================================== ====================== 6. Date on which issuer 19th December 2016 notified: ============================================== ====================== 7. Threshold(s) that is/are crossed or reached: vi, vii 3% ============================================== ====================== 8. Notified details: =================================================================================================== A: Voting rights attached to shares viii, ix =================================================================================================== Class/type Situation Resulting situation after of shares previous to the triggering transaction the triggering if possible transaction using the ISIN CODE ============= ======================== ========================================================== Number Number Number Number of % of voting of Shares of Voting of shares voting rights rights x Rights ============= =========== =========== =========== ===================== ====================== Indirect Direct Direct xii Direct Indirect xi ============= =========== =========== =========== ========== ========= ========= =========== GB00B92JR 174 136,551 136,551 417,631 417,631 N/a 3.76% N/a ============= =========== =========== =========== ========== ========= ========= =========== B: Qualifying Financial Instruments ====================================================================== Resulting situation after the triggering transaction ====================================================================== Type of financial Expirati Exercise/ Number of % of voting voting instrument on Conversion rights that rights may be date Period xiv acquired if xiii the instrument is exercised/ converted. ================== ========= =========== ============ ============ N/a N/a N/a N/a N/a ================== ========= =========== ============ ============ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi ================================================================================= Resulting situation after the triggering transaction ================================================================================= Type of Exercis Expirat Exercise/ Number of % of voting voting financial e price ion Conversio rights instrument rights xix, xx instrument date n period refers to xvii xviii =========== ======== ======== ========== ================== ================ Nominal Delta =========== ======== ======== ========== ================== ======== ====== N/a N/a N/a N/a N/a N/a N/a =========== ======== ======== ========== ================== ======== ====== Total (A+B+C) =================================================== Number of voting rights Percentage of voting rights =========================== ====================== 417,631 3.76% =========================== ====================== 9. Chain of controlled undertakings through which the voting rights and/ or the financial instruments are effectively held, if applicable: xxi --------------------------------------------------- N/a =================================================== Proxy Voting: =========================================== 10. Name of the proxy holder: N/a =================================== ====== 11. Number of voting rights proxy holder will cease to N/a hold: =================================== ====== 12. Date on which proxy holder will cease to hold voting rights: N/a =================================== ====== 13. Additional information: =============================== ================== 14. Contact name: Terry Richards =============================== ================== 15. Contact telephone number: +61 408 123 401 =============================== ==================
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBUBDDUBBBGLC
(END) Dow Jones Newswires
December 19, 2016 10:18 ET (15:18 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions